![We Care for Every Heartbeat]({"type":"image" , "src" : "/sda/112416/JournalAd-TACD-Daiichi.jpg"})
https://orcid.org/0000-0001-8838-814X
References
- Gornik HL, Creager MA. Aortitis. Circulation. 2008;117(23):3039–3051.
- Cho S-J, Park S-M, Ryu S-M, et al. Nonaneurysmal infectious aortitis. Ann Vasc Surg. 2014;28(5):1313.e13–1313.e16.
- Wilson WR, Bower TC, Creager MA, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American heart Association. Circulation. 2016;134(20):e412–e460.
- Akashi Y, Ikehara Y, Yamamoto A, et al. Purulent pericarditis due to group B streptococcus and mycotic aneurysm of the ascending aorta: case report. Jpn Circ J. 2000;64(1):83–86.
- Ballaith A, Raffort J, Rajhi K, et al. Mycotic aortic and left iliac ruptured aneurysm due to Escherichia coli: a case report and literature overview. Acta Chir Belg. 2020;21:1–7.
- Takagi H, Nachi S, Matsuno Y, et al. Chronic contained rupture of the descending thoracic aorta due to infection by Escherichia coli. Heart Vessels. 2005;20(4):186–189.
- Takahashi Y, Tsutsumi Y, Monta O, et al. Mycotic aneurysm of the thoracic aorta caused by extended-spectrum beta-lactamase-producing Escherichia coli. Interact Cardiovasc Thorac Surg. 2011;12(1):61–62.
- Helleman JN, Hendriks JMH, Deblier I, et al. Mycotic aneurysm of the descending thoracic aorta. Review and case report. Acta Chir Belg. 2007;107(5):544–547.
- Hsu R-B, Lin F-Y. Infected aneurysm of the thoracic aorta. J Vasc Surg. 2008;47(2):270–276.
- McCann JF, Fareed A, Reddy S, et al. Multi-resistant Escherichia coli and mycotic aneurysm: two case reports. J Med Case Rep. 2009;3:6453.
- Rajendran R, Malik H, Richardson T. Escherichia coli and mycotic thoracic aortic aneurysm: a case report. Gd Rounds. 2012;12(1):27–31.
- Yano M, Hayase T, Furukawa K, et al. Mycotic pseudoaneurysm of the ascending aorta caused by Escherichia coli. Interact Cardiovasc Thorac Surg. 2013;16(1):81–83.
- Sörelius K, Wanhainen A, Wahlgren C-M, et al. Nationwide study on treatment of mycotic thoracic aortic aneurysms. Eur J Vasc Endovasc Surg. 2019;57(2):239–246.
- Pasternak B, Inghammar M, Svanström H. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 2018;360:k678.
- Lee C-C, Lee M-TG, Chen Y-S, et al. Risk of aortic dissection and aortic aneurysm in patients taking oral Fluoroquinolone. JAMA Intern Med. 2015;175(11):1839–1847.
- Carino D, Zafar MA, Singh M, et al. Fluoroquinolones and aortic diseases: is there a connection. Aorta. 2019;7(2):35–41.
- Coselli JS, Crawford ES, Williams TW, et al. Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flaps. Ann Thorac Surg. 1990;50(6):868–881.
- Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg. 1999;67(6):1990–1993; discussion 1997–1998.
- Czerny M, von Allmen R, Opfermann P, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg. 2011;92(5):1657–1662.
- Corvera JS, Blitzer D, Copeland H, et al. Repair of thoracic and thoracoabdominal mycotic aneurysms and infected aortic grafts using allograft. Ann Thorac Surg. 2018;106(4):1129–1135.
![Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.]({"type":"image" , "src" : "/sda/112387/JournalAd-TACD-BOEHR-MPU.jpg"})
![Novartis. Your partner in Heart Failure & Atherosclerosis >>]({"type":"image" , "src" : "/sda/112381/JournalAd-TACD-Novartis-Skyscraper.jpg"})